News. 08/02/18

Procuritas invests in PressData Stockholm Intressenter AB

Procuritas Capital Investors VI invests in PressData Stockholm Intressenter AB (”PDI Group”), a company with operations in media and member subscription services, text similarity detection and content digitization.

PDI Group is based in Stockholm, Sweden and operates primarily through Urkund, Pressdata and Paperton. Urkund is the Nordic market leader in text similarity detection with a global customer base and strong growth trajectory. The company offers its products to e.g. corporates, authorities, academic institutions and publishers. Pressdata is the leading provider of media and member subscription services in Sweden for magazines, newspapers and membership organizations. Paperton enables digitization of media content to fit every reader platform.

Current management has successfully built and led PDI Group for several years through innovative industry solutions that are expected to grow in significance and contribute to higher efficiency among end customers in Sweden and abroad. As part of investing in the future, the organization will be further strengthened to enable realization of the ambitious plan focusing on organic growth and product innovation.

Andreas Ohlson, CEO at PDI Group, says – “Our success to date is driven by our strong company culture and focus on customers. We look forward to continue our journey with Procuritas, a professional partner that shares our values, enabling an acceleration in development and taking our business to the next level”.

Johan Conradsson, Partner at Procuritas, continues – “We are very happy about PDI Group becoming a Procuritas company. We believe that there are great opportunities for continued strong growth and development of innovative solutions that simplifies and increases efficiency for our end customers”.

Keith Fransson, Chairman at PDI, adds – “I look forward to work with PDI Group and Procuritas, and to embark on our future journey together.”

For further information, please contact:

Johan Conradsson, Partner, Procuritas Capital Investors VI Holding AB
tel. +46 8 506 143 00

Andreas Ohlsson, CEO, PDI Group
tel. +46 8 738 47 77

About PDI
PDI is operates in text similarity detection through Urkund, media and member subscription services through Pressdata and content digitization through Paperton. The company is headquartered in Stockholm, Sweden and employs about 30 people.

About PCI VI
Procuritas Capital Investors (”PCI VI”) is a private equity fund focusing on mid-sized companies in the Nordic region. PCI VI launched in 2017, with ca. MEUR 318 in committed capital. With a passion for business, extensive industrial experience and more than thirty years’ track record covering a large variety of transactions, Procuritas has supported over 40 companies with the aim to accelerate their growth and realize their true business potential.

More news.

09/04/24

Polarn O. Pyret appoints Sara Sjöberg as new CEO

Procuritas Capital Investors VI (”Procuritas”), the Swedish private equity firm dedicated to growing Nordic mid-market enterprises, is delighted to announce the appointment of Sara Sjöberg as the forthcoming Chief Executive Officer for its portfolio company, Polarn O. Pyret, the iconic Swedish childrenswear brand. Sara Sjöberg steps into this role with a wealth of experience from...

08/04/24

Humana to acquire Team Olivia’s Norwegian operation

Team Olivia, a leading care service provider in the Nordics has entered into an agreement to sell its Norwegian operations, Team Olivia Norge AS, to Human Care Holding AS (“Humana”). The Transaction is subject to approval by the Norwegian competition authority and is expected to be completed during the second quarter of 2024. Team Olivia,...

28/02/24

Procuritas partners up with Precision BioLogic

Procuritas Capital Investors VII (Procuritas) acquires Precision BioLogic (PBI) and subsidiary (Affinity Biologicals), fast-growing niche leaders in hemostasis diagnostics and research. PBI has in recent years launched a number of successful diagnostics products and is active in a growing market, supported by long-term trends such as ageing population, emerging new therapies, and increased access to...